Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

ATF7IP-PDGFRB fusion

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

ATF7IP-PDGFRB fusion	Acute Lymphocytic Leukemia	ATF7IP-PDGFRB fusion	Acute Lymphocytic Leukemia	dasatinib Sensitive: C4 – Case Studies dasatinib Sensitive : C4	dasatinib Sensitive: C4 – Case Studies dasatinib Sensitive : C4
ATF7IP-PDGFRB fusion	B Acute Lymphoblastic Leukemia	ATF7IP-PDGFRB fusion	B Acute Lymphoblastic Leukemia	Tyrosine kinase inhibitor Sensitive: C4 – Case Studies Tyrosine kinase inhibitor Sensitive : C4	Tyrosine kinase inhibitor Sensitive: C4 – Case Studies Tyrosine kinase inhibitor Sensitive : C4
ATF7IP-PDGFRB fusion	Acute Lymphocytic Leukemia	ATF7IP-PDGFRB fusion	Acute Lymphocytic Leukemia	imatinib Sensitive: D – Preclinical imatinib Sensitive : D	imatinib Sensitive: D – Preclinical imatinib Sensitive : D